Report : Asia Pacific Cardiovascular Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Device [Electrocardiography (ECG), Pacemaker, Stent, Defibrillator, Cardiac Catheter, Guidewire, Heart Valve, Event Monitor, and Others], Application (Coronary Heart Disease, Sudden Cardiac Arrest, Stroke, Cerebrovascular Heart Disease, and Others), and End-User (Hospitals, Ambulatory Surgery Centers, and Cardiac Centers)
Hospitals Segment to Dominate Asia Pacific Cardiovascular Devices market Forecast to 2028 during 2019–2028
According to a new market research study on the Asia Pacific Cardiovascular Devices market Forecast to 2028 –– by device, application vertical and countries is expected to reach US$ 14,846.18 million by 2028 from US$ 8,991.10 million in 2021. The market is estimated to grow at a CAGR of 7.4% from 2021 to 2028. The report provides trends prevailing in the Asia Pacific Cardiovascular Devices market along with the drivers and restraints pertaining to the market growth. Increasing prevalence of cardiovascular diseases is the major factor driving the growth of the Asia Pacific Cardiovascular Devices market. However, issues associated with high cost of products and procedures the growth of Asia Pacific Cardiovascular Devices market.
The Asia Pacific Cardiovascular Devices market segmented into device, application, end user and country. Based on device the Asia Pacific Cardiovascular Devices market is segmented into electrocardiography (ECG), pacemaker, stent, defibrillator, cardiac catheter, guidewire, heart valve, event monitor, and others. The event monitor segment is dominated Asia Pacific Cardiovascular Devices market in 2020.Based on application the Asia Pacific Cardiovascular Devices market segmented into coronary heart disease, sudden cardiac arrest, stroke, cerebrovascular heart disease and others. The coronary heart disease segment Asia Pacific Cardiovascular Devices market Dominated in 2020. Based on end-user the Asia Pacific Cardiovascular Devices market segmented into hospitals, ambulatory surgery centers and cardiac centers. The hospitals segment is dominated Asia Pacific Cardiovascular Devices market in 2020.Based on country, The Asia Pacific Cardiovascular Devices market segmented into China, Japan, India, South Korea, Australia and RoAPAC. The Japan is dominated the Asia Pacific Cardiovascular Devices market in 2020.
Medtronic, Boston Scientific Corporation, Abbott, Jhonson and Jhonson Service Inc, General Electric Company,Koninlijke Philips N.V, Siemens Healthineers AG, BD,B.Bruna melsungen AG and Edwards Lifesciences Corporation are among the leading companies in Asia Pacific Cardiovascular Devices market. For instance, Nov-2021 Royal Philips announced that it had signed an agreement to acquire Cardiologs, a France-based medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology. Cardiologs will further strengthen Philips’ cardiac monitoring and diagnostics offering with innovative software technology, electrocardiogram (ECG) analysis and reporting services. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in dynamic market.
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email Id: sales@businessmarketinsights.com